Assessing administrative costs of mental health and substance abuse services

Administration and Policy in Mental Health
Robert W BroylesMadeline J Robertson

Abstract

Increasing competition in the market for mental health and substance abuse MHSA services and the potential to realize significant administrative savings have created an imperative to monitor, evaluate, and control spending on administrative functions. This paper develops a generic model that evaluates spending on administrative personnel by a group of providers. The precision of the model is demonstrated by examining a set of data assembled from five MHSA service providers. The model examines a differential cost construction derived from inter-facility comparisons of administrative expenses. After controlling for the scale of operations, the results enable MHSA programs to control the efficiency of administrative personnel and related rates of compensation. The results indicate that the efficiency of using the administrative complement and the scale of operations represent the lion's share of the total differential cost. The analysis also indicates that a modest improvement in the use of administrative personnel results in substantial cost savings, an increase in the net cash flow derived from operations, an improvement in the fiscal performance of the provider, and a decline in opportunity costs that assume the form of foregon...Continue Reading

Citations

Oct 22, 2011·Community Mental Health Journal·Arthur EvansMark Salzer
Jan 20, 2006·The Journal of Primary Prevention·Paul J BrounsteinThomas Backer
May 16, 2009·The Journal of Primary Prevention·Thao N LeJudy Wallen
Jun 6, 2006·The Journal of Behavioral Health Services & Research·Gordon Hannah, Judy Hall
Jul 25, 2007·The Journal of Behavioral Health Services & Research·Van M TaAnne Duggan
Mar 14, 2012·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Enrique R PougetHannah L F Cooper
Sep 14, 2006·Current Psychiatry Reports·Robert F FormanA Thomas McLellan
Jul 29, 2004·Current Treatment Options in Neurology·Robert D. DaviesKelly Woyewodzic
Jul 2, 2009·Mayo Clinic Proceedings·William L Lanier, Evan D Kharasch
Jan 25, 2005·Lancet·Derrick Silove, Anthony B Zwi
Apr 15, 2010·Disaster Medicine and Public Health Preparedness·Carol S FullertonRobert J Ursano
Oct 30, 2008·Journal of Addictive Diseases·Yih-Ing HserElizabeth Evans
Apr 22, 2010·Journal of Addictive Diseases·Annemarie UngerGabriele Fischer
Jun 15, 2011·Journal of Social Work in Disability & Rehabilitation·Elspeth Slayter
Jul 21, 1998·Annals of the New York Academy of Sciences·K Kaltenbach, L Finnegan
Jun 13, 2006·Substance Abuse Treatment, Prevention, and Policy·Steve SussmanToby Miller
Jun 18, 2011·Implementation Science : IS·Douglas K NovinsUNKNOWN Centers for American Indian and Alaska Native Health's Substance Abuse Treatment Advisory Board
Jun 17, 2008·Journal of Addictive Diseases·Angela M WisniewskiRichard D Blondell
Dec 14, 2007·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Edward BernsteinPatricia Owens
Jul 23, 2010·Journal of Psychoactive Drugs·Philip R LeeM Arch
Jun 20, 2019·Journal of Substance Use·Amy A MericleDouglas L Polcin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.